Webinar Overview
In recent years, pharma and biotech companies have focused much of their preclinical research on studies leveraging research mice with highly targeted mutations. When planning a project, the first option many researchers consider is creating a typical CRISPR B6 knockout mouse, but could this be limiting the possibilities of science?
View this webinar for a discussion on designing sophisticated models for improved predictability and these topics:
- Mouse background and technology alternatives
- The rat model and advantages of species other than mice
- Ethics, quality control, and validation
- Best practice for importing transgenic rodents
Webinar Presenters
Guillaume Pavlovic, PhD
Head of Unit - Genetic Engineering and Model Validation
PHENOMIN-ICS - IGBMC
Jean Cozzi, PhD
Innovation Manager, Genetically Engineered Models and Services
Charles River